Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-23

Clinical Trial Update: Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS) [Phase 1, Phase 2]

View source ↗

Summary

A Phase I/II clinical trial evaluating sodium thiosulfate as oto-protection during cisplatin therapy for solid tumors; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sodium thiosulfate (sodium thiosulfate)

Snippet

Sponsor: University of Arizona | Conditions: Solid Tumor Malignancies, Testicular Cancer | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING